Lucia Leccisotti

17PUBLICATIONS
60CO-AUTHORS
Predictive and prognostic markersPharmaceutical delivery technologiesImmunogenetics (incl. genetic immunology)Solid tumoursPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|May 27, 2026
The Role of PET Tracers in Small-Cell Prostate Cancer (SCPC): An Overview in Clinical and Preclinical Settings.

|Sep 27, 2025
Peptide Receptor Radionuclide Therapy (PRRT) Using Actinium-225- and Ac-225/Lutetium-177-Labeled (TANDEM) Somatostatin Receptor Antagonist DOTA-LM3 in Patients with Neuroendocrine Neoplasm: A Retrospective Study Concerning Safety and Survival.

Elisabetta Perrone, Maria Lucia Calcagni, Lucia Leccisotti

|Aug 28, 2025
Role of 18F FDG-PET-CT in Fever and Inflammation of Unknown Origin.

Elena Romano Gargarella, Flaminia Vocaturo, Andrea Guarneri

|Jul 29, 2025
In Vivo Versus In Vitro Somatostatin Receptor Expression in Neuroendocrine Neoplasms: A Systematic Review and Meta-Analysis of Correlation Studies.

Elisabetta Perrone, Giorgio Treglia, Romina Grazia Giancipoli

|Feb 26, 2025
The Predictive Role of Baseline 18F-FDG PET/CT Radiomics in Follicular Lymphoma on Watchful Waiting: A Preliminary Study.

Daria Maccora, Michele Guerreri, Rosalia Malafronte

|Feb 26, 2025
13N-Ammonia PET-CT for Evaluating Response to Antiangiogenic Therapy and Prognosis in Patients with Advanced Hepatocellular Carcinoma: A Pilot Study.

Valentina Scolozzi, Alberto Nicoletti, Amedeo Capotosti

Pageof 3

Frequent Collaborators

3 joint publications

Giorgio Treglia

3 joint publications

Elisabetta Perrone

2 joint publications

Domenico Albano

2 joint publications

Tanay Parkar